Common Equity: The sum of all common equity items.
Capstone Therapeutics Corp. (CAPS) had Common Equity of $-1.24M for the most recently reported fiscal year, ending 2018-12-31.
| Income Statement Financials | |
$2.00M |
|
$-0.38M |
|
$0.25M |
|
$1.75M |
|
$2.18M |
|
$-0.18M |
|
$-0.25M |
|
$-0.43M |
|
$-0.43M |
|
$-0.38M |
|
$-0.38M |
|
$-0.38M |
|
$-0.38M |
|
$-0.18M |
|
$-0.02M |
|
0.05M |
|
0.05M |
|
$-10.00 |
|
$-10.00 |
|
| Balance Sheet Financials | |
$1.44M |
|
-- |
|
$0.04M |
|
$1.48M |
|
$0.25M |
|
$2.48M |
|
$2.48M |
|
$2.72M |
|
|
Common Equity |
$-1.24M |
$-1.28M |
|
$-1.24M |
|
0.05M |
|
| Cash Flow Statement Financials | |
$0.07M |
|
-- |
|
-- |
|
$1.27M |
|
$1.34M |
|
$0.07M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.85 |
|
-- |
|
-- |
|
2.01 |
|
-1.99 |
|
87.30% |
|
-9.05% |
|
-9.05% |
|
-1.20% |
|
-21.60% |
|
-19.00% |
|
$0.07M |
|
-- |
|
-- |
|
-- |
|
1.35 |
|
-- |
|
-- |
|
-- |
|
30.55% |
|
29.62% |
|
-25.73% |
|
-30.87% |
|
$-22.87 |
|
$1.21 |
|
$1.21 |
|